Summit Wealth & Retirement Planning’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-2,763
Closed -$307K – 117
2022
Q1
$307K Buy
2,763
+84
+3% +$8.87K 0.11% 84
2021
Q4
$277K Sell
2,679
-2,370
-47% -$274K 0.09% 79
2021
Q3
$633K Buy
+5,049
New +$653K 0.23% 54

Other funds holding MDT

Summit Wealth & Retirement Planning's MDT Position: Q2 2022 in Review

Summit Wealth & Retirement Planning sold out of Medtronic (MDT) in Q2 2022, closing a stake of 2,763 shares — an estimated $307K sold.

Summit Wealth & Retirement Planning first reported a position in MDT in Q3 2021 and held it in 3 quarters. The position peaked at $633K in Q3 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Summit Wealth & Retirement Planning reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Summit Wealth & Retirement Planning sold 2,763 Medtronic shares in Q2 2022, an estimated $307K.
  • Summit Wealth & Retirement Planning first reported a position in Medtronic in Q3 2021 and held it in 3 quarters.
  • Summit Wealth & Retirement Planning's Medtronic position peaked at $633K in Q3 2021.
  • 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Summit Wealth & Retirement Planning's 13F filing for Q2 2022, filed 2 Aug 2022.